biotechnology

The company plans wide-ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client…

Dr Mahesh Bhalgat, COO, Syngene talks about his company's outlook, investments and capacity expansion, as well as Syngene's plans…

A high-level delegation from Colombia led by Marta Lucia Ramirez de Rincón, Vice-President and Minister, Foreign Affairs, visited…

The first phase is expected to be completed by December 2022.

Dr Jeremy Levin, Chairman and CEO, Ovid Therapeutics and former board member of Biocon talks about the scope of the biotech…

The scheme enables technology innovators and entrepreneurs to pursue a promising technology idea, and establish and validate POC…

Ryaltris is a new fixed‐dose combination nasal spray of an antihistamine and a steroid indicated for treatment of symptoms…

Lupin Biotech, with a new-age R&D facility in Pune, is developing and commercialising biosimilars globally. The successful…

The network funding aims facilitate early-stage private capital to accelerate the growth of startups operating in biotech,…

Dr Bhalgat is recognised for his contribution to the commercialization of diagnostic kits, biopharmaceuticals and WHO…